Aberrant processing of human proislet amyloid polypeptide results in increased amyloid formation

Diabetes

Volumn 54, Issue 7, 2005, Pages 2117-2125

  Paulsson, Johan F ^a   Westermark, Gunilla T ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN; COMPLEMENTARY DNA; MESSENGER RNA; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONFOCAL MICROSCOPY; DIABETES MELLITUS; GENE EXPRESSION; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS ISLET BETA CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

AMINO ACID SEQUENCE; AMYLOID; ANIMALS; BASE SEQUENCE; CERCOPITHECUS AETHIOPS; COS CELLS; DNA PRIMERS; GENE EXPRESSION REGULATION; HUMANS; ISLETS OF LANGERHANS; MICE; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PROPROTEIN CONVERTASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS;

EID: 21344470854     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.54.7.2117     Document Type: Article

References (52)

1. Westermark P: Quantitative studies of amyloid in the islets of Langerhans. Ups J Med Sci 77:91-94, 1972
2. Clark A, Charge SB, Badman MK, MacArthur DA, de Koning EJ: Islet amyloid polypeptide: actions and role in the pathogenesis of diabetes. Biochem Soc Trans 24:594-599, 1996
3. Zhao HL, Lai FM, Tong PC, Zhong DR, Yang D, Tomlinson B, Chan JC: Prevalence and clinicopathological characteristics of islet amyloid in Chinese patients with type 2 diabetes. Diabetes 52:2759-2766, 2003
4. Westermark P, Grimelius L: The pancreatic islet cells in insular amyloidosis in human diabetic and non-diabetic adults. Acta Path Microbiol Scand A 81:291-300, 1973
5. Clark A, Wells C, Buley I, Cruickshank J, Vanhegan R, Matthews D, Cooper G, Holman RR, Turner RC: Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Res 9:151-159, 1988
6. Butler A, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC: Deficit and increased B-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102-110, 2003
7. Westermark P, Wernstedt C, Wilander E, Sletten K: A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas. Biochem Biophys Res Commun 140:827-831, 1986
8. Cooper GJ, Willis AC, Clark A, Turner RC, Sim RB, Reid KB: Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci U S A 84:8628-8632, 1987
9. Johnson KH, O'Brien TD, Hayden DW, Jordan K, Ghobrial HK, Mahoney WC, Westermark P: Immunolocalization of islet amyloid polypeptide (LAPP) in pancreatic beta cells by means of peroxidase-antiperoxidase (PAP) and protein A-gold techniques. Am J Pathol 130:1-8, 1988
10. Kahn SE, D'Alessio DA, Schwartz MW, Pujimoto WY, Ensinck JW, Taborsky GJ Jr, Porte D Jr: Evidence of cosecretion of islet amyloid polypeptide and insulin by β-cells. Diabetes 39:634-638, 1990
11. Butler PC, Chou J, Carter WB, Wang YN, Bu BH, Chang D, Chang JK, Rizza RA: Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans. Diabetes 39:752-756, 1990
12. Sanke T, Bell GI, Sample C, Rubenstein A, Steiner DF: An islet amyloid peptide is derived from an 89-amino acid precursor by proteolytic processing. J Biol Chem 263:17243-17246, 1988
13. Bailyes E, Shennan KI, Usac E, Arden S, Guest PC, Docherty K, Hutton J: Differences between the catalytic properties of recombinant human PC2 and endogenous rat PC2. Biochem J 309:587-594, 1995
14. Higham CE, Hull RL, Lawrie L, Shennan KI, Morris JF, Birch NP, Docherty K, Clark A: Processing of synthetic pro-islet amyloid polypeptide (proIAPP) "amylin" by recombinant prohormone convertase enzymes, PC2 and PC3, in vitro. Eur J Biochem 267:4998-5004, 2000
15. Wang J, Xu J, Finnerty J, Furuta M, Steiner DF, Verchere CB: The prohormone convertase enzyme 2 (PC2) is essential for processing proislet amyloid polypeptide at the NH2-terminal cleavage site. Diabetes 50:534-539, 2001
16. Marzban L, Trigo-Gonzalez G, Zhu X, Rhodes CJ, Halban PA, Steiner DF, Verchere CB: Role of β-cell prohormone convertase (PC)1/3 in processing of pro-islet amyloid polypeptide. Diabetes 53:141-148, 2004
17. De Koning EJ, Hoppener JW, Oosterwijk C, Verbeek SJ, Visser HJ, Jansz HS, Lips CJ, Morris JF, Clark A: Localisation of islet amyloid polypeptide (IAPP) in pancreatic islets of transgenic mice expressing the human or rat IAPP gene. Biochem Soc Trans 21:268, 1993
18. D'Alessio DA, Verchere CB, Kahn SE, Hoagland V, Baskin DG, Palmiter RD, Ensinck JW: Pancreatic expression and secretion of human islet amyloid polypeptide in a transgenic mouse. Diabetes 43:1457-1461, 1994
19. Westermark G, Arora MB, Fox N, Carroll R, Chan SJ, Westermark P, Steiner DF: Amyloid formation in response to beta cell stress occurs in vitro, but not in vivo, in islets of transgenic mice expressing human islet amyloid polypeptide. Mol Med 1:542-553, 1995
20. Soeller WC, Janson J, Hart SE, Parker JC, Carty MD, Stevenson RW, Kreutter DK, Butler PC: Islet amyloid-associated diabetes in obese A(vy)/a mice expressing human islet amyloid polypeptide. Diabetes 47:743-750, 1998
21. Hoppener JW, Oosterwyk C, Nieuwenhuis MG, Posthuma G, Thijssen JH, Vroom TM, Ahren B, Lips CJ: Extensive islet amyloid formation is induced by development of Type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model. Diabetologia 42:427-434, 1999
22. Verchere CB, D'Alessio DA, Palmiter RD, Weir GC, Bonner-Weir S, Baskin DG, Kahn SE: Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide. Proc Natl Acad Sci U S A 93:3492-3496, 1996
23. Westermark GT, Gebre-Medhin S, Steiner DF, Westermark P: Islet amyloid development in a mouse strain lacking endogenous islet amyloid polypeptide (IAPP) but expressing human IAPP. Mol Med 6:998-1007, 2000
24. Westermark P: Fine structure of islet of Langerhans in insular amyloidosis. Virchows Arch A 359:1-18, 1973
25. Westermark P, Eizirik DL, Pipeleers DG, Hellerstrom C, Andersson A: Rapid deposition of amyloid in human islets transplanted into nude mice. Diabetologia 38:543-549, 1995
26. O'Brien TD, Butler AE, Roche PC, Johnson KH, Butler PC: Islet amyloid polypeptide in human insulinomas. Evidence for intracellular amyloidogenesis. Diabetes 43:329-336, 1994
27. Jackson R, Creemers J, Ohagi S, Raffin-Sanson M, Sanders L, Montague C, Hutton J, O'Rahilly S: Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat Genet 16:303-306, 1997
28. Kahn SE, Halban PA: Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM. Diabetes 46:1725-1732, 1997
29. Guest PC, Abdel-Halim SM, Gross DJ, Clark A, Poitout V, Amaria R, Ostenson CG, Hutton JC: Proinsulin processing in the diabetic Goto-Kakizaki rat. J Endocrinol 175:637-647, 2002
30. Krampert M, Bernhagen J, Schmucker J, Horn A, Schmauder A, Brunner H, Voelter W, Kapurniotu A: Amyloidogenicity of recombinant human proislet amyloid polypeptide (ProIAPP). Chem Biol 7:855-871, 2000
31. Betsholtz C, Svensson V, Rorsman F, Engstrom U, Westermark GT, Wilander E, Johnson K, Westermark P: Islet amyloid polypeptide (IAPP): cDNA cloning and identification of an amyloidogenic region associated with the species-specific occurrence of age-related diabetes mellitus. Exp Cell Res 183:484-493, 1989
32. Fischer D, Bieber T, Li Y, Elsasser HP, Kissel T: A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity. Pharm Res 16:1273-1279, 1999
33. Ma Z, Westermark GT, Li ZC, Engström U, Westermark P: Altered immunoreactivity of islet amyloid polypeptide (IAPP) may reflect major modifications of the IAPP molecule in amyloidogenesis. Diabetologia 40:793-801, 1997
34. Christmanson L, Betsholtz C, Leckström A, Engstrom U, Cortie C, Johnson KH, Adrian TE, Westermark P: Islet amyloid polypeptide in the rabbit and European hare: studies on its relationship to amyloidogenesis. Diabetologia 36:183-188, 1993
35. Puchtler H, Sweat F, Kuhns JG: On the binding of direct cotton dyes by amyloid. J Histochem Cytochem 12:900-907, 1964
36. Puchtler H, Sweat F: Congo red as a stain for fluorescence microscopy of amyloid. J Histochem Cytochem 13:693-694, 1965
37. O'Brien TD, Butler PC, Kreutter DK, Kane LA, Eberhardt NL: Human islet amyloid polypeptide expression in COS-1 cells. A model of intracellular amyloidogenesis. Am J Pathol 147:609-616, 1995
38. Hiddinga HJ, Eberhardt NL: Intracellular amyloidogenesis by human islet amyloid polypeptide induces apoptosis in COS-1 cells. Am J Pathol 154:1077-1088, 1999
39. Kapurniotu A, Bernhagen J, Greenfield N, Al-Abed Y, Teichberg S, Frank RW, Voelter W, Bucala R: Contribution of advanced glycosylation to the amyloidogenicity of islet amyloid polypeptide. Eur J Biochem 251:208-216, 1998
40. Westermark P, Li ZC, Westermark GT, Leckström A, Steiner DF: Effects of beta cell granule components on human islet amyloid polypeptide fibril formation. FEBS Lett 379:203-206, 1996
41. Janciauskiene S, Eriksson S, Carlemalm E, Ahren B: B cell granule peptides affect human islet amyloid polypeptide (IAPP) fibril formation in vitro. Biochem Biophys Res Commun 236:580-585, 1997
42. Kudva YC, Mueske C, Butler PC, Eberhardt NL: A novel assay in vitro of human islet amyloid polypeptide amyloidogenesis and effects of insulin secretory vesicle peptides on amyloid formation. Biochem J 331:809-813, 1998
43. Jaikaran ET, Nilsson MR, Clark A: Pancreatic beta-cell granule peptides form heteromolecular complexes which inhibit islet amyloid polypeptide fibril formation. Biochem J 377:709-716, 2004
44. Opie E: On relation of chronic interstitial pancreatitis to the islands of Langerhans and to diabetes mellitus. J Exp Med 5:397-428, 1901
45. MacArthur DL, de Koning EJ, Verbeek JS, Morris JF, Clark A: Amyloid fibril formation is progressive and correlates with beta-cell secretion in transgenic mouse isolated islets. Diabelologia 42:1219-1227, 1999
46. Westermark P, Wernstedt C, Wilander E, Hayden DW, O'Brien TD, Johnson KH: Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci U S A 84:3881-3885, 1987
47. Rochet JC, Lansbury PT Jr. Amyloid fibrillogenesis: themes and variations. Curr Opin Struct Biol 10:60-68, 2000
48. O'Nuallain B, Williams AD, Westermark P, Wetzel R: Seeding specificity in amyloid growth induced by heterologous fibrils. J Biol Chem 279:17490-17499, 2004
49. Robertson RP: Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem 279:42351-42354, 2004
50. Sakuraba H, Mizukami H, Yagihashi N, Wada R, Hanyu C, Yagihashi S: Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients. Diabetologia 45:85-96, 2002
51. Bedwell S, Dean R, Jessup W: The action of defined oxygen-centred free radicals on human low-density lipoprotein. Biochem J 262:707-712, 1989
52. Knight JD, Miranker AD: Phospholipid catalysis of diabetic amyloid assembly. J Mol Biol 341:1175-1187, 2004